SEC Form 4 · accession 0000920465-17-000093
LA JOLLA PHARMACEUTICAL CO · LJPC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jennifer Carver
Officer — Chief Operating Officer
Period of report
Dec 27, 2017
Accepted (ET)
Dec 29, 2017 · 5:07 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000920465
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 27, 2017 | P | 1,000 | $33.215 | A | 4,500 | D |
Table II — derivative securities
No Table II lines on this filing.